# Arzneimittelausschreibung 2026\_vergebene Aufträge Awarded · Tender **This opportunity has been awarded. Its page stays for reference.** Similar open opportunities: - [Lieferung von 68 m³ MGO-Gasöl (unversteuert) für den Maschinenbetrieb des VWFS DENEB & des VS CAPELLA am 28.07.2026 im Stadthafen von Rostock](https://inteliwert.com/tender/opp_4FX1VEYMJ8QZXRGGX1E29BVRPK/lieferung-von-68-m-mgo-gasoel-unversteuert-fuer-den-maschinenbetrieb-des-vwfs-de) - [Arzneimittel mit dem Wirkstoff Nebivolol (ATC: C07AB12)](https://inteliwert.com/tender/opp_4VP64RP4YFW98HHTKB7X7FV1YD/arzneimittel-mit-dem-wirkstoff-nebivolol-atc-c07ab12) - [Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V ab dem 01.09.2026](https://inteliwert.com/tender/opp_6SA269X2NSGP5428J75D8SG2XC/abschluss-nicht-exklusiver-rabattvereinbarungen-nach-130-a-abs-8-sgb-v-ab-dem-01) - [Arzneimittel mit dem Wirkstoff Aprepitant (ATC: A04AD12 - in der Darreichungsform Hartkapseln)](https://inteliwert.com/tender/opp_98EQRTD2JB8AY1FPDSSMZDMSX5/arzneimittel-mit-dem-wirkstoff-aprepitant-atc-a04ad12-in-der-darreichungsform-ha) - [Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens](https://inteliwert.com/tender/opp_AF7JN3331VNYKY5GCGQVCD2NA0/abschluss-nicht-exklusiver-rabattvereinbarungen-nach-130a-abs-8-sgb-v-zu-verschi) ## At a glance IKK classic is procuring Pharmaceutical products (CPV 33600000). It is divided into 257 lots and has been awarded. Procedure type: Open. ### From the notice Abschluss von Rabattverträgen nach § 130a Abs. 8 SGB V mit einer regulären Laufzeit von 2 Jahren. Vertragsbeginn ist der 01.01.2027. Die Verträge zu den Fachlosen mit der Losnummer 005, 011, 016, 031, 034, 040, 042, 065, 083, 090, 096, 098, 107, 110, 119, 122, 129, 139, 142, 144, 150, 152, 162, 173, 177, 180, 202, 204, 208, 216, 236 und 237 beginnen abweichend von dem regulären Vertragsbeginn (1. Januar 2027) bereits ab dem 01.10.2026. Die Laufzeit der Verträge zu diesen Fachlosen beträgt damit 27 Monate. Die Ausschreibung erfolgt wirkstoffbezogen für die aufgeführten Wirkstoffe und Wirkstoffkombinationen, aufgeteilt in 257 Fachlose. Angebote können ausschließlich nur für verschreibungspflichtige Arzneimittel abgegeben werden. Ausnahmen sind die Fachlose mit der Losnummer 097 (WNK 04 bis 09) und 146 (WNK 04 und 05), in denen jeweils ausschließlich nicht-verschreibungspflichtige, apothekenpflichtige Arzneimittel angeboten werden dürfen. Pro Fachlos wird eine Rabattvereinbarung mit maximal einem, zwei oder drei pharmazeutischen Unternehmern (Bieter oder Bietergemeinschaft) geschlossen (zur Höchstzahl siehe Informationen zum jeweiligen Fachlos). ## Key facts - Status: Awarded - Deadline: No deadline in the notice - Buyer: [IKK classic](https://inteliwert.com/company/org_M8A59T7B5HWET5RKPP2HXCFF4V/ikk-classic), Dresden, DE - Main CPV: Pharmaceutical products (CPV 33600000) - Procedure: Open - Lots: 257 - First published: 27 July 2026, 15:42 (UTC+02:00) Source: [Official notice](https://oeffentlichevergabe.de/ui/de/notices/f51d4024-f7de-438f-b5f4-73e94e513e03). Each fact is from the official notice, last checked 9 November 2026, 20:30 (UTC+01:00). ## Lots (257) ### Lot LOT-0001: 001 | Acetylsalicylsäure magensaftresistente Tabletten u.w. \[3\] \[H\] ATC-Code: B01AC06; Acetylsalicylsäure Darreichungsform(en): Granulat; Kautabletten; magensaftresistente Tabletten; Tabletten; überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €662,842 excl. VAT ### Lot LOT-0002: 002 | Agomelatin Filmtabletten \[3\] ATC-Code: N06AX22; Agomelatin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €489,005 excl. VAT ### Lot LOT-0003: 003 | Alendronsäure Tabletten u.w. \[2\] ATC-Code: M05BA04; Alendronsäure Darreichungsform(en): Brausetabletten; Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €847,633 excl. VAT ### Lot LOT-0004: 004 | Allopurinol Tabletten \[3\] ATC-Code: M04AA01; Allopurinol Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €950,165 excl. VAT ### Lot LOT-0005: 005 | Amifampridin Tabletten \[1\] ATC-Code: N07XX05; Amifampridin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €427,767 excl. VAT ### Lot LOT-0006: 006 | Amisulprid Filmtabletten \[2\] ATC-Code: N05AL05; Amisulprid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €272,927 excl. VAT ### Lot LOT-0007: 007 | Amisulprid Tabletten \[3\] ATC-Code: N05AL05; Amisulprid Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €443,988 excl. VAT ### Lot LOT-0008: 008 | Amitriptylin Filmtabletten u.w. \[2\] ATC-Code: N06AA09; Amitriptylin Darreichungsform(en): Filmtabletten; Tabletten; überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €689,008 excl. VAT ### Lot LOT-0009: 009 | Amlodipin Tabletten \[3\] ATC-Code: C08CA01; Amlodipin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,652,640 excl. VAT ### Lot LOT-0010: 010 | Anagrelid Hartkapseln \[2\] ATC-Code: L01XX35; Anagrelid Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €455,487 excl. VAT ### Lot LOT-0011: 011 | Apremilast Filmtabletten \[3\] ATC-Code: L04AA32; Apremilast Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €866,300 excl. VAT ### Lot LOT-0012: 012 | Aprepitant Hartkapseln \[2\] ATC-Code: A04AD12; Aprepitant Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €138,588 excl. VAT ### Lot LOT-0013: 013 | Atenolol Filmtabletten u.w. \[2\] ATC-Code: C07AB03; Atenolol Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €68,962 excl. VAT ### Lot LOT-0014: 014 | Atomoxetin Hartkapseln \[3\] ATC-Code: N06BA09; Atomoxetin Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €421,487 excl. VAT ### Lot LOT-0015: 015 | Atorvastatin + Ezetimib Filmtabletten u.w. \[2\] ATC-Code: C10BA05; Atorvastatin + Ezetimib Darreichungsform(en): Filmtabletten; Hartkapseln; Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €2,722,952 excl. VAT ### Lot LOT-0016: 016 | Atovaquon Suspension zum Einnehmen \[1\] ATC-Code: P01AX06; Atovaquon Darreichungsform(en): Suspension zum Einnehmen Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €98,025 excl. VAT ### Lot LOT-0017: 017 | Azathioprin Filmtabletten u.w. \[2\] ATC-Code: L04AX01; Azathioprin Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €617,329 excl. VAT ### Lot LOT-0018: 018 | Azelastin + Fluticason Nasenspray \[1\] ATC-Code: R01AD58; Azelastin + Fluticason Darreichungsform(en): Nasenspray Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €240,653 excl. VAT ### Lot LOT-0019: 019 | Betamethason + Salicylsäure Salbe \[1\] ATC-Code: D07XC01; Betamethason + Salicylsäure Darreichungsform(en): Salbe Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €156,449 excl. VAT ### Lot LOT-0020: 020 | Betamethason Creme \[1\] ATC-Code: D07AC01; Betamethason Darreichungsform(en): Creme Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €211,504 excl. VAT ### Lot LOT-0021: 021 | Betamethason Emulsion \[1\] ATC-Code: D07AC01; Betamethason Darreichungsform(en): Emulsion Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €136,912 excl. VAT ### Lot LOT-0022: 022 | Betamethason Lösung \[1\] ATC-Code: D07AC01; Betamethason Darreichungsform(en): Lösung Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €127,669 excl. VAT ### Lot LOT-0023: 023 | Betamethason Salbe \[1\] ATC-Code: D07AC01; Betamethason Darreichungsform(en): Salbe Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €58,660 excl. VAT ### Lot LOT-0024: 024 | Bicalutamid Filmtabletten \[2\] ATC-Code: L02BB03; Bicalutamid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €384,408 excl. VAT ### Lot LOT-0025: 025 | Bimatoprost + Timolol EDO \[2\] ATC-Code: S01ED51; Bimatoprost + Timolol Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €413,198 excl. VAT ### Lot LOT-0026: 026 | Bimatoprost EDO \[1\] ATC-Code: S01EE03; Bimatoprost Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €288,667 excl. VAT ### Lot LOT-0027: 027 | Bisoprolol + Hydrochlorothiazid Filmtabletten \[2\] ATC-Code: C07BB07; Bisoprolol + Hydrochlorothiazid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €321,627 excl. VAT ### Lot LOT-0028: 028 | Bisoprolol Filmtabletten u.w. \[3\] ATC-Code: C07AB07; Bisoprolol Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €2,507,223 excl. VAT ### Lot LOT-0029: 029 | Bosentan Filmtabletten \[2\] ATC-Code: C02KX01; Bosentan Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,697,386 excl. VAT ### Lot LOT-0030: 030 | Brinzolamid Augentropfen \[2\] ATC-Code: S01EC04; Brinzolamid Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €607,346 excl. VAT ### Lot LOT-0031: 031 | Budesonid Hartkapseln mit veränderter Wirkstofffreisetzung \[1\] ATC-Code: A07EA06; Budesonid Darreichungsform(en): Hartkapseln mit veränderter Wirkstofffreisetzung Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €298,162 excl. VAT ### Lot LOT-0032: 032 | Budesonid Suspension für einen Vernebler \[2\] ATC-Code: R03BA02; Budesonid Darreichungsform(en): Suspension für einen Vernebler Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €495,424 excl. VAT ### Lot LOT-0033: 033 | Buprenorphin + Naloxon Sublingualtabletten \[1\] ATC-Code: N07BC51; Buprenorphin + Naloxon Darreichungsform(en): Sublingualtabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €34,183 excl. VAT ### Lot LOT-0034: 034 | Buprenorphin Pflaster transdermal Tragedauer 3 Tage \[1\] \[H\] ATC-Code: N02AE01; Buprenorphin Darreichungsform(en): Pflaster transdermal Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €138,811 excl. VAT ### Lot LOT-0035: 035 | Bupropion Tabletten mit veränderter Wirkstofffreisetzung \[3\] ATC-Code: N06AX12; Bupropion Darreichungsform(en): Tabletten mit veränderter Wirkstofffreisetzung Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €2,520,709 excl. VAT ### Lot LOT-0036: 036 | Cabergolin Tabletten \[1\] ATC-Code: G02CB03; Cabergolin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €147,740 excl. VAT ### Lot LOT-0037: 037 | Candesartan + Amlodipin Tabletten u.w. \[2\] ATC-Code: C09DB07; Candesartan + Amlodipin Darreichungsform(en): Hartkapseln; Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €2,038,709 excl. VAT ### Lot LOT-0038: 038 | Candesartan + Hydrochlorothiazid Tabletten \[3\] ATC-Code: C09DA06; Candesartan + Hydrochlorothiazid Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €2,484,538 excl. VAT ### Lot LOT-0039: 039 | Candesartan Tabletten \[3\] ATC-Code: C09CA06; Candesartan Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €10,344,179 excl. VAT ### Lot LOT-0040: 040 | Carglumsäure Tabletten zur Herstellung ei. Suspension z. Einnehmen \[1\] ATC-Code: A16AA05; Carglumsäure Darreichungsform(en): Tablette zur Herstellung einer Suspension zum Einnehmen Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,415,752 excl. VAT ### Lot LOT-0041: 041 | Carvedilol Tabletten u.w. \[3\] ATC-Code: C07AG02; Carvedilol Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €657,846 excl. VAT ### Lot LOT-0042: 042 | Chinin Filmtabletten \[1\] ATC-Code: P01BC01; Chinin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €804,717 excl. VAT ### Lot LOT-0043: 043 | Chlormadinon + Ethinylestradiol Filmtabletten \[2\] \[H\] ATC-Code: G03AA15; Chlormadinon + Ethinylestradiol Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €61,190 excl. VAT ### Lot LOT-0044: 044 | Citalopram Filmtabletten \[3\] ATC-Code: N06AB04; Citalopram Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €781,122 excl. VAT ### Lot LOT-0045: 045 | Clopidogrel Filmtabletten \[2\] ATC-Code: B01AC04; Clopidogrel Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,208,950 excl. VAT ### Lot LOT-0046: 046 | Clozapin Tabletten \[2\] ATC-Code: N05AH02; Clozapin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €898,442 excl. VAT ### Lot LOT-0047: 047 | Colecalciferol + Fluorid-Ion Tabletten \[1\] \[H\] ATC-Code: A11CC55; Colecalciferol + Fluorid-Ion Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €71,764 excl. VAT ### Lot LOT-0048: 048 | Colecalciferol Tropfen zum Einnehmen \[1\] ATC-Code: A11CC05; Colecalciferol Darreichungsform(en): Tropfen zum Einnehmen Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €94,877 excl. VAT ### Lot LOT-0049: 049 | Colestyramin Pulver zur Herstellung einer Suspension zum Einnehmen u.w. \[1\] ATC-Code: C10AC01; Colestyramin Darreichungsform(en): Granulat zur Herstellung einer Suspension zum Einnehmen; Pulver zur Herstellung einer Suspension zum Einnehmen; Pulver Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €278,904 excl. VAT ### Lot LOT-0050: 050 | Cyanocobalamin Filmtabletten u.w. \[1\] \[H\] ATC-Code: B03BA01; Cyanocobalamin Darreichungsform(en): Filmtabletten; überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €206,196 excl. VAT ### Lot LOT-0051: 051 | Cyproteron + Ethinylestradiol überzogene Tabletten u.w. \[1\] ATC-Code: G03HB01; Cyproteron + Estrogen Darreichungsform(en): Filmtabletten; überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €24,569 excl. VAT ### Lot LOT-0052: 052 | Dabigatran Hartkapseln \[2\] ATC-Code: B01AE07; Dabigatran Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €921,005 excl. VAT ### Lot LOT-0053: 053 | Darunavir Filmtabletten \[2\] ATC-Code: J05AE10; Darunavir Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €366,029 excl. VAT ### Lot LOT-0054: 054 | Dasatinib Filmtabletten \[3\] ATC-Code: L01EA02; Dasatinib Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,311,167 excl. VAT ### Lot LOT-0055: 055 | Desmopressin Tabletten \[1\] ATC-Code: H01BA02; Desmopressin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €591,888 excl. VAT ### Lot LOT-0056: 056 | Diclofenac Augentropfen \[1\] ATC-Code: S01BC03; Diclofenac Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €36,558 excl. VAT ### Lot LOT-0057: 057 | Diclofenac Gel AK \[1\] \[H\] ATC-Code: D11AX18; Diclofenac Darreichungsform(en): Gel Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,064,137 excl. VAT ### Lot LOT-0058: 058 | Diclofenac Tabletten magensaftresistent u.w. \[2\] ATC-Code: M01AB05; Diclofenac Darreichungsform(en): Filmtabletten; Hartkapseln; Hartkapseln mit veränderter Wirkstofffreisetzung; magensaftresistente Hartkapseln; magensaftresistente Tabletten; Tabletten zur Herstellung einer Suspension zum Einnehmen; überzogene Tabletten; Weichkapseln Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €68,370 excl. VAT ### Lot LOT-0059: 059 | Dienogest + Estradiol valerat Tabletten u.w. \[2\] ATC-Code: G03FA15; Dienogest + Estradiol valerat Darreichungsform(en): Filmtabletten; Tabletten; überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €212,378 excl. VAT ### Lot LOT-0060: 060 | Donepezil Filmtabletten u.w. \[2\] ATC-Code: N06DA02; Donepezil Darreichungsform(en): Filmtabletten; Schmelztabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €572,176 excl. VAT ### Lot LOT-0061: 061 | Doxazosin Retardtabletten \[2\] ATC-Code: C02CA04; Doxazosin Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €204,369 excl. VAT ### Lot LOT-0062: 062 | Doxazosin Tabletten \[2\] \[H\] ATC-Code: C02CA04; Doxazosin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €595,598 excl. VAT ### Lot LOT-0063: 063 | Doxepin Filmtabletten u.w. \[3\] ATC-Code: N06AA12; Doxepin Darreichungsform(en): Filmtabletten; Hartkapseln; Tabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €302,485 excl. VAT ### Lot LOT-0064: 064 | Dutasterid Weichkapseln \[1\] ATC-Code: G04CB02; Dutasterid Darreichungsform(en): Weichkapseln Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €89,581 excl. VAT ### Lot LOT-0065: 065 | Eltrombopag Filmtabletten \[3\] \[H\] ATC-Code: B02BX05; Eltrombopag Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €899,552 excl. VAT ### Lot LOT-0066: 066 | Emtricitabin, Tenofovir + Efavirenz Filmtabletten \[2\] ATC-Code: J05AR06; Emtricitabin, Tenofovirdisoproxil + Efavirenz Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €512,606 excl. VAT ### Lot LOT-0067: 067 | Enalapril + Hydrochlorothiazid Tabletten \[2\] ATC-Code: C09BA02; Enalapril + Hydrochlorothiazid Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €190,024 excl. VAT ### Lot LOT-0068: 068 | Enalapril + Lercanidipin Filmtabletten \[2\] ATC-Code: C09BB02; Enalapril + Lercanidipin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €497,502 excl. VAT ### Lot LOT-0069: 069 | Enoxaparin Injektionslösung in einer Fertigspritze \[2\] ATC-Code: B01AB05; Enoxaparin Darreichungsform(en): Injektionslösung in einer Fertigspritze Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €5,397,408 excl. VAT ### Lot LOT-0070: 070 | Entacapon Filmtabletten \[1\] ATC-Code: N04BX02; Entacapon Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €39,122 excl. VAT ### Lot LOT-0071: 071 | Entecavir Filmtabletten \[2\] ATC-Code: J05AF10; Entecavir Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €298,737 excl. VAT ### Lot LOT-0072: 072 | Erlotinib Filmtabletten \[1\] ATC-Code: L01EB02; Erlotinib Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €37,223 excl. VAT ### Lot LOT-0073: 073 | Eslicarbazepin Tabletten \[3\] ATC-Code: N03AF04; Eslicarbazepin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €254,039 excl. VAT ### Lot LOT-0074: 074 | Ethosuximid Weichkapseln \[2\] ATC-Code: N03AD01; Ethosuximid Darreichungsform(en): Weichkapseln Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €102,983 excl. VAT ### Lot LOT-0075: 075 | Etoricoxib Filmtabletten \[3\] ATC-Code: M01AH05; Etoricoxib Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,962,275 excl. VAT ### Lot LOT-0076: 076 | Everolimus Tabletten \[2\] \[H\] ATC-Code: L01EG02; Everolimus Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €270,507 excl. VAT ### Lot LOT-0077: 077 | Exemestan Filmtabletten u.w. \[3\] ATC-Code: L02BG06; Exemestan Darreichungsform(en): Filmtabletten; überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €258,507 excl. VAT ### Lot LOT-0078: 078 | Fampridin Retardtabletten \[3\] ATC-Code: N07XX07; Fampridin Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,444,578 excl. VAT ### Lot LOT-0079: 079 | Febuxostat Filmtabletten \[3\] ATC-Code: M04AA03; Febuxostat Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €332,751 excl. VAT ### Lot LOT-0080: 080 | Felodipin Retardtabletten \[2\] ATC-Code: C08CA02; Felodipin Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €254,081 excl. VAT ### Lot LOT-0081: 081 | Fentanyl Lutschtabletten \[1\] ATC-Code: N02AB03; Fentanyl Darreichungsform(en): Lutschtabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €48,375 excl. VAT ### Lot LOT-0082: 082 | Fentanyl Pflaster transdermal I \[2\] ATC-Code: N02AB03; Fentanyl Darreichungsform(en): Pflaster transdermal Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €822,136 excl. VAT ### Lot LOT-0083: 083 | Fentanyl Pflaster transdermal II \[1\] ATC-Code: N02AB03; Fentanyl Darreichungsform(en): Pflaster transdermal Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €40,508 excl. VAT ### Lot LOT-0084: 084 | Fentanyl Sublingualtabletten \[1\] ATC-Code: N02AB03; Fentanyl Darreichungsform(en): Sublingualtabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €757,139 excl. VAT ### Lot LOT-0085: 085 | Fexofenadin Filmtabletten \[2\] ATC-Code: R06AX26; Fexofenadin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €385,841 excl. VAT ### Lot LOT-0086: 086 | Finasterid Filmtabletten \[3\] ATC-Code: G04CB01; Finasterid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €639,231 excl. VAT ### Lot LOT-0087: 087 | Fluconazol Hartkapseln u.w. \[2\] ATC-Code: J02AC01; Fluconazol Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €744,475 excl. VAT ### Lot LOT-0088: 088 | Fluorouracil + Salicylsäure Lösung \[1\] ATC-Code: L01BC52; Fluorouracil + Salicylsäure Darreichungsform(en): Lösung Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €195,347 excl. VAT ### Lot LOT-0089: 089 | Fluoxetin Tabletten u.w. \[3\] ATC-Code: N06AB03; Fluoxetin Darreichungsform(en): Filmtabletten; Hartkapseln; Tabletten; Tabletten zur Herstellung einer Suspension zum Einnehmen Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €486,208 excl. VAT ### Lot LOT-0090: 090 | Formoterol + Beclomethason Dosieraerosol \[3\] ATC-Code: R03AK08; Formoterol + Beclomethason Darreichungsform(en): Dosieraerosol Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €10,205,410 excl. VAT ### Lot LOT-0091: 091 | Fosaprepitant Pulver zur Herstellung einer Infusionslösung \[1\] ATC-Code: A04AD12; Fosaprepitant Darreichungsform(en): Pulver zur Herstellung einer Infusionslösung Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €317,262 excl. VAT ### Lot LOT-0092: 092 | Fulvestrant Injektionslösung in einer Fertigspritze u.w. \[3\] ATC-Code: L02BA03; Fulvestrant Darreichungsform(en): Injektionslösung; Injektionslösung in einer Fertigspritze Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €493,124 excl. VAT ### Lot LOT-0093: 093 | Furosemid Tabletten \[2\] ATC-Code: C03CA01; Furosemid Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €234,536 excl. VAT ### Lot LOT-0094: 094 | Galantamin Retardkapseln \[2\] ATC-Code: N06DA04; Galantamin Darreichungsform(en): Retardkapseln Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €52,700 excl. VAT ### Lot LOT-0095: 095 | Glimepirid Tabletten \[2\] ATC-Code: A10BB12; Glimepirid Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €259,427 excl. VAT ### Lot LOT-0096: 096 | Guanfacin Retardtabletten \[1\] ATC-Code: C02AC02; Guanfacin Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,292,206 excl. VAT ### Lot LOT-0097: 097 | Hydrocortison Creme \[1\] \[H\] ATC-Code: D07AA02; Hydrocortison Darreichungsform(en): Creme Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €39,124 excl. VAT ### Lot LOT-0098: 098 | Hydrocortison Tabletten \[2\] ATC-Code: H02AB09; Hydrocortison Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €557,745 excl. VAT ### Lot LOT-0099: 099 | Hydromorphon Hartkapseln \[2\] ATC-Code: N02AA03; Hydromorphon Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,306,758 excl. VAT ### Lot LOT-0100: 100 | Hydroxycarbamid Hartkapseln \[2\] ATC-Code: L01XX05; Hydroxycarbamid Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €340,103 excl. VAT ### Lot LOT-0101: 101 | Hydroxyzin Filmtabletten \[1\] ATC-Code: N05BB01; Hydroxyzin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €26,220 excl. VAT ### Lot LOT-0102: 102 | Ibandronsäure Filmtabletten \[1\] ATC-Code: M05BA06; Ibandronsäure Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €129,389 excl. VAT ### Lot LOT-0103: 103 | Ibandronsäure Infusionslösungskonzentrat \[1\] ATC-Code: M05BA06; Ibandronsäure Darreichungsform(en): Infusionslösungskonzentrat Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €105,572 excl. VAT ### Lot LOT-0104: 104 | Ibandronsäure Injektionslösung \[2\] ATC-Code: M05BA06; Ibandronsäure Darreichungsform(en): Injektionslösung Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €322,663 excl. VAT ### Lot LOT-0105: 105 | Ibuprofen Filmtabletten u.w. \[2\] ATC-Code: M01AE01; Ibuprofen Darreichungsform(en): Filmtabletten; Kautabletten; Tabletten; Weichgelatinekapseln; Kapseln; überzogene Tabletten; Schmelztabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €3,283,399 excl. VAT ### Lot LOT-0106: 106 | Imiquimod Creme \[1\] ATC-Code: D06BB10; Imiquimod Darreichungsform(en): Creme Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €365,756 excl. VAT ### Lot LOT-0107: 107 | Ipratropiumbromid Dosieraerosol \[1\] ATC-Code: R03BB01; Ipratropiumbromid Darreichungsform(en): Dosieraerosol Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €84,168 excl. VAT ### Lot LOT-0108: 108 | Irbesartan + Hydrochlorothiazid Filmtabletten \[3\] ATC-Code: C09DA04; Irbesartan + Hydrochlorothiazid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €153,411 excl. VAT ### Lot LOT-0109: 109 | Ketorolac Augentropfen \[1\] ATC-Code: S01BC05; Ketorolac Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €39,175 excl. VAT ### Lot LOT-0110: 110 | Lactulose Sirup \[2\] \[H\] ATC-Code: A06AD11; Lactulose Darreichungsform(en): Sirup Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €208,050 excl. VAT ### Lot LOT-0111: 111 | Lansoprazol magensaftresistente Hartkapseln u.w. \[2\] ATC-Code: A02BC03; Lansoprazol Darreichungsform(en): Magensaftresistente Hartkapseln; Kapseln magensaftresistent Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €75,247 excl. VAT ### Lot LOT-0112: 112 | Lanthan(III)-carbonat Kautabletten \[1\] ATC-Code: V03AE03; Lanthan(III)-carbonat Darreichungsform(en): Kautabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €551,748 excl. VAT ### Lot LOT-0113: 113 | Latanoprost Augentropfen \[2\] ATC-Code: S01EE01; Latanoprost Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,212,252 excl. VAT ### Lot LOT-0114: 114 | Latanoprost Einzeldosispipetten \[1\] ATC-Code: S01EE01; Latanoprost Darreichungsform(en): Einzeldosispipetten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,272,238 excl. VAT ### Lot LOT-0115: 115 | Leflunomid Filmtabletten u.w. \[2\] ATC-Code: L04AK01; Leflunomid Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,431,277 excl. VAT ### Lot LOT-0116: 116 | Lenalidomid Hartkapseln \[3\] ATC-Code: L04AX04; Lenalidomid Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €398,282 excl. VAT ### Lot LOT-0117: 117 | Letrozol Filmtabletten \[3\] ATC-Code: L02BG04; Letrozol Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €654,598 excl. VAT ### Lot LOT-0118: 118 | Levetiracetam Filmtabletten \[3\] ATC-Code: N03AX14; Levetiracetam Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €2,352,368 excl. VAT ### Lot LOT-0119: 119 | Levetiracetam Granulat \[1\] ATC-Code: N03AX14; Levetiracetam Darreichungsform(en): Granulat Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €47,340 excl. VAT ### Lot LOT-0120: 120 | Levetiracetam Infusionslösungskonzentrat \[1\] ATC-Code: N03AX14; Levetiracetam Darreichungsform(en): Infusionslösungskonzentrat Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €34,605 excl. VAT ### Lot LOT-0121: 121 | Levodopa + Benserazid Retardkapseln \[1\] ATC-Code: N04BA02; Levodopa + Benserazid Darreichungsform(en): Retardkapseln Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €797,847 excl. VAT ### Lot LOT-0122: 122 | Levodopa + Carbidopa Retardtabletten \[2\] ATC-Code: N04BA02; Levodopa + Carbidopa Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €281,402 excl. VAT ### Lot LOT-0123: 123 | Levonorgestrel + Ethinylestradiol Filmtabletten \[2\] ATC-Code: G03AA07; Levonorgestrel + Ethinylestradiol Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €323,662 excl. VAT ### Lot LOT-0124: 124 | Levonorgestrel + Ethinylestradiol überzogene Tabletten \[2\] ATC-Code: G03AA07; Levonorgestrel + Ethinylestradiol Darreichungsform(en): Überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €141,550 excl. VAT ### Lot LOT-0125: 125 | Lisdexamfetamin Hartkapseln \[2\] ATC-Code: N06BA12; Lisdexamfetamin Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €3,777,219 excl. VAT ### Lot LOT-0126: 126 | Lisinopril + Hydrochlorothiazid Tabletten \[2\] ATC-Code: C09BA03; Lisinopril + Hydrochlorothiazid Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €189,292 excl. VAT ### Lot LOT-0127: 127 | Lisinopril Tabletten \[2\] ATC-Code: C09AA03; Lisinopril Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €233,342 excl. VAT ### Lot LOT-0128: 128 | Lorazepam Tabletten u.w. \[2\] ATC-Code: N05BA06; Lorazepam Darreichungsform(en): Lyophilisat zum Einnehmen; Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €285,774 excl. VAT ### Lot LOT-0129: 129 | Mebeverin Retardkapseln u.w. \[1\] ATC-Code: A03AA04; Mebeverin Darreichungsform(en): Hartkapseln, retardiert; Hartkapseln mit veränderter Wirkstofffreisetzung; Retardkapseln Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €110,008 excl. VAT ### Lot LOT-0130: 130 | Mesalazin Suppositorien \[2\] ATC-Code: A07EC02; Mesalazin Darreichungsform(en): Suppositorien Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €759,356 excl. VAT ### Lot LOT-0131: 131 | Mesalazin Tabletten magensaftresistent \[1\] ATC-Code: A07EC02; Mesalazin Darreichungsform(en): Tabletten magensaftresistent Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €781,708 excl. VAT ### Lot LOT-0132: 132 | Metamizol natrium Tabletten u.w. \[2\] ATC-Code: N02BB02; Metamizol-Natrium Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €4,776,515 excl. VAT ### Lot LOT-0133: 133 | Metamizol natrium Tropfen zum Einnehmen u.w. \[2\] ATC-Code: N02BB02; Metamizol-Natrium Darreichungsform(en): Tropfen zum Einnehmen; Lösung; Tropfen Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,412,194 excl. VAT ### Lot LOT-0134: 134 | Metformin Filmtabletten \[3\] ATC-Code: A10BA02; Metformin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €3,356,442 excl. VAT ### Lot LOT-0135: 135 | Methocarbamol Filmtabletten u.w. \[2\] ATC-Code: M03BA03; Methocarbamol Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €2,001,479 excl. VAT ### Lot LOT-0136: 136 | Methylphenidat Hartkapseln mit veränderter Wirkstofffreisetzung \[1\] \[H\] ATC-Code: N06BA04; Methylphenidat Darreichungsform(en): Hartkapseln mit veränderter Wirkstofffreisetzung Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €146,102 excl. VAT ### Lot LOT-0137: 137 | Methylphenidat Retardtabletten \[2\] ATC-Code: N06BA04; Methylphenidat Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,008,468 excl. VAT ### Lot LOT-0138: 138 | Metoprolol succinat Retardtabletten \[2\] ATC-Code: C07AB02; Metoprolol Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €3,618,070 excl. VAT ### Lot LOT-0139: 139 | Metoprolol tartrat Retardtabletten mit ZOK-Kinetik \[2\] \[H\] ATC-Code: C07AB02; Metoprolol Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €124,929 excl. VAT ### Lot LOT-0140: 140 | Metoprolol tartrat Retardtabletten ohne ZOK-Kinetik \[2\] ATC-Code: C07AB02; Metoprolol Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €176,572 excl. VAT ### Lot LOT-0141: 141 | Metoprolol tartrat Tabletten \[2\] ATC-Code: C07AB02; Metoprolol Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €197,032 excl. VAT ### Lot LOT-0142: 142 | Midazolam Injektionslösung u.w. \[1\] ATC-Code: N05CD08; Midazolam Darreichungsform(en): Injektionslösung; Infusionslösung; Injektions-/Infusionslösung; Ampullen Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €72,539 excl. VAT ### Lot LOT-0143: 143 | Milnacipran Hartkapseln \[1\] ATC-Code: N06AX17; Milnacipran Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €75,406 excl. VAT ### Lot LOT-0144: 144 | Minoxidil Tabletten \[2\] ATC-Code: C02DC01; Minoxidil Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €665,363 excl. VAT ### Lot LOT-0145: 145 | Mirtazapin Filmtabletten u.w. \[3\] ATC-Code: N06AX11; Mirtazapin Darreichungsform(en): Filmtabletten; Schmelztabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €2,300,359 excl. VAT ### Lot LOT-0146: 146 | Mometason Nasenspray u.w. \[2\] \[H\] ATC-Code: R01AD09; Mometason Darreichungsform(en): Nasenspray; Suspension; Nasendosierspray Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €632,835 excl. VAT ### Lot LOT-0147: 147 | Morphin sulfat Filmtabletten u.w. \[1\] ATC-Code: N02AA01; Morphin Darreichungsform(en): Filmtabletten; Hartkapseln Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €268,296 excl. VAT ### Lot LOT-0148: 148 | Moxonidin Filmtabletten \[2\] ATC-Code: C02AC05; Moxonidin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,651,900 excl. VAT ### Lot LOT-0149: 149 | Multienzyme magensaftresistente Hartkapseln u.w. \[2\] \[H\] ATC-Code: A09AA02; Triacylglycerollipase Darreichungsform(en): Magensaftresistente, polydisperse Mikrotabletten in Kapseln; Magensaftresistente, polydisperse Pellets in Beuteln; Magensaftresistente, polydisperse Pellets in Kapseln; Magensaftresistentes, polydisperses Granulat in Beuteln; magensaftresistente Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €5,555,630 excl. VAT ### Lot LOT-0150: 150 | Naproxen + Esomeprazol Tabletten mit veränderter Wirkstofffreisetzung \[1\] ATC-Code: M01AE52; Naproxen + Esomeprazol Darreichungsform(en): Tablette mit veränderter Wirkstofffreisetzung Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €249,070 excl. VAT ### Lot LOT-0151: 151 | Naratriptan Filmtabletten \[2\] ATC-Code: N02CC02; Naratriptan Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €151,549 excl. VAT ### Lot LOT-0152: 152 | Nilotinib Hartkapseln \[2\] ATC-Code: L01EA03; Nilotinib Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €4,150,194 excl. VAT ### Lot LOT-0153: 153 | Nitisinon Hartkapseln \[1\] ATC-Code: A16AX04; Nitisinon Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €705,270 excl. VAT ### Lot LOT-0154: 154 | Olanzapin Filmtabletten u.w. \[3\] ATC-Code: N05AH03; Olanzapin Darreichungsform(en): Filmtabletten; Schmelztabletten; Tabletten; überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,867,997 excl. VAT ### Lot LOT-0155: 155 | Olmesartan, Amlodipin + Hydrochlorothiazid Filmtabletten \[3\] ATC-Code: C09DX03; Olmesartan medoxomil, Amlodipin + Hydrochlorothiazid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €720,240 excl. VAT ### Lot LOT-0156: 156 | Omeprazol magensaftresistente Hartkapseln u.w. \[3\] ATC-Code: A02BC01; Omeprazol Darreichungsform(en): magensaftresistente Hartkapseln; magensaftresistente Tabletten; Kapseln magensaftresistent Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,845,574 excl. VAT ### Lot LOT-0157: 157 | Oxycodon + Naloxon Retardtabletten \[3\] ATC-Code: N02AA55; Oxycodon + Naloxon Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €2,210,072 excl. VAT ### Lot LOT-0158: 158 | Paliperidon Depot-Injektionssuspension \[2\] \[H\] ATC-Code: N05AX13; Paliperidon Darreichungsform(en): Depot-Injektionssuspension Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €3,225,518 excl. VAT ### Lot LOT-0159: 159 | Pantoprazol Tabletten magensaftresistent \[3\] ATC-Code: A02BC02; Pantoprazol Darreichungsform(en): Tabletten magensaftresistent Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €6,996,120 excl. VAT ### Lot LOT-0160: 160 | Paricalcitol Injektionslösung \[1\] ATC-Code: H05BX02; Paricalcitol Darreichungsform(en): Injektionslösung Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €492,749 excl. VAT ### Lot LOT-0161: 161 | Paricalcitol Weichkapseln \[1\] ATC-Code: H05BX02; Paricalcitol Darreichungsform(en): Weichkapseln Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €124,833 excl. VAT ### Lot LOT-0162: 162 | Pazopanib Filmtabletten \[2\] ATC-Code: L01EX03; Pazopanib Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €678,198 excl. VAT ### Lot LOT-0163: 163 | Perindopril arginin + Indapamid Filmtabletten u.w. \[1\] ATC-Code: C09BA04; Perindopril + Indapamid Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €734,047 excl. VAT ### Lot LOT-0164: 164 | Pipamperon Lösung zum Einnehmen \[1\] ATC-Code: N05AD05; Pipamperon Darreichungsform(en): Lösung zum Einnehmen Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €338,879 excl. VAT ### Lot LOT-0165: 165 | Pipamperon Tabletten \[1\] ATC-Code: N05AD05; Pipamperon Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €821,472 excl. VAT ### Lot LOT-0166: 166 | Pomalidomid Hartkapseln \[2\] ATC-Code: L04AX06; Pomalidomid Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,511,318 excl. VAT ### Lot LOT-0167: 167 | Pramipexol Retardtabletten \[3\] ATC-Code: N04BC05; Pramipexol Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,039,128 excl. VAT ### Lot LOT-0168: 168 | Prasugrel Filmtabletten \[2\] ATC-Code: B01AC22; Prasugrel Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €810,767 excl. VAT ### Lot LOT-0169: 169 | Pravastatin Tabletten u.w. \[2\] ATC-Code: C10AA03; Pravastatin Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €178,302 excl. VAT ### Lot LOT-0170: 170 | Prednisolon Tabletten \[3\] ATC-Code: H02AB06; Prednisolon Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,097,973 excl. VAT ### Lot LOT-0171: 171 | Pregabalin Hartkapseln u.w. \[3\] ATC-Code: N02BF02; Pregabalin Darreichungsform(en): Hartkapseln; Tabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €5,119,295 excl. VAT ### Lot LOT-0172: 172 | Pregabalin Lösung zum Einnehmen \[1\] ATC-Code: N02BF02; Pregabalin Darreichungsform(en): Lösung zum Einnehmen Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €58,138 excl. VAT ### Lot LOT-0173: 173 | Pridinol Tabletten \[1\] ATC-Code: M03BX03; Pridinol Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €2,076,211 excl. VAT ### Lot LOT-0174: 174 | Promethazin Filmtabletten u.w. \[1\] ATC-Code: R06AD02; Promethazin Darreichungsform(en): Filmtabletten; überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €143,243 excl. VAT ### Lot LOT-0175: 175 | Prucaloprid Filmtabletten \[2\] ATC-Code: A06AX05; Prucaloprid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €483,328 excl. VAT ### Lot LOT-0176: 176 | Pyridostigmin Retardtabletten \[1\] ATC-Code: N07AA02; Pyridostigmin Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €430,301 excl. VAT ### Lot LOT-0177: 177 | Pyridostigmin überzogene Tabletten u.w. \[1\] ATC-Code: N07AA02; Pyridostigmin Darreichungsform(en): überzogene Tabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €110,282 excl. VAT ### Lot LOT-0178: 178 | Quetiapin Filmtabletten \[3\] ATC-Code: N05AH04; Quetiapin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €2,028,562 excl. VAT ### Lot LOT-0179: 179 | Quetiapin Retardtabletten \[3\] ATC-Code: N05AH04; Quetiapin Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €599,172 excl. VAT ### Lot LOT-0180: 180 | Raltegravir Filmtabletten \[1\] ATC-Code: J05AJ01; Raltegravir Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €185,453 excl. VAT ### Lot LOT-0181: 181 | Ramipril + Hydrochlorothiazid Tabletten \[2\] ATC-Code: C09BA05; Ramipril + Hydrochlorothiazid Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,364,230 excl. VAT ### Lot LOT-0182: 182 | Ramipril Tabletten \[3\] ATC-Code: C09AA05; Ramipril Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €3,036,130 excl. VAT ### Lot LOT-0183: 183 | Rasagilin Tabletten \[3\] ATC-Code: N04BD02; Rasagilin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €200,985 excl. VAT ### Lot LOT-0184: 184 | Repaglinid Tabletten \[2\] ATC-Code: A10BX02; Repaglinid Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €62,403 excl. VAT ### Lot LOT-0185: 185 | Risperidon Filmtabletten \[3\] ATC-Code: N05AX08; Risperidon Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €595,421 excl. VAT ### Lot LOT-0186: 186 | Risperidon Lösung zum Einnehmen \[1\] ATC-Code: N05AX08; Risperidon Darreichungsform(en): Lösung zum Einnehmen Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €34,505 excl. VAT ### Lot LOT-0187: 187 | Rivastigmin Hartkapseln \[2\] ATC-Code: N06DA03; Rivastigmin Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €435,668 excl. VAT ### Lot LOT-0188: 188 | Rivastigmin Pflaster transdermal \[3\] ATC-Code: N06DA03; Rivastigmin Darreichungsform(en): Pflaster transdermal Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €880,509 excl. VAT ### Lot LOT-0189: 189 | Rizatriptan Schmelztabletten \[2\] ATC-Code: N02CC04; Rizatriptan Darreichungsform(en): Schmelztabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €296,232 excl. VAT ### Lot LOT-0190: 190 | Rizatriptan Tabletten \[2\] ATC-Code: N02CC04; Rizatriptan Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €137,311 excl. VAT ### Lot LOT-0191: 191 | Ropinirol Retardtabletten \[3\] ATC-Code: N04BC04; Ropinirol Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €320,471 excl. VAT ### Lot LOT-0192: 192 | Rosuvastatin + Ezetimib Filmtabletten u.w. \[2\] ATC-Code: C10BA06; Rosuvastatin + Ezetimib Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €2,991,042 excl. VAT ### Lot LOT-0193: 193 | Rosuvastatin Filmtabletten \[3\] ATC-Code: C10AA07; Rosuvastatin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €3,070,443 excl. VAT ### Lot LOT-0194: 194 | Rupatadin Tabletten \[1\] ATC-Code: R06AX28; Rupatadin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €165,748 excl. VAT ### Lot LOT-0195: 195 | Sertralin Filmtabletten \[3\] ATC-Code: N06AB06; Sertralin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €2,286,901 excl. VAT ### Lot LOT-0196: 196 | Sevelamer carbonat Pulver zur Herstellung einer Suspension zum Einnehmen \[1\] ATC-Code: V03AE02; Sevelamer Darreichungsform(en): Pulver zur Herstellung einer Suspension zum Einnehmen Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €82,968 excl. VAT ### Lot LOT-0197: 197 | Simvastatin Filmtabletten \[2\] ATC-Code: C10AA01; Simvastatin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,826,458 excl. VAT ### Lot LOT-0198: 198 | Sitagliptin + Metformin Filmtabletten \[3\] ATC-Code: A10BD07; Sitagliptin + Metformin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €2,970,173 excl. VAT ### Lot LOT-0199: 199 | Sitagliptin Filmtabletten \[2\] ATC-Code: A10BH01; Sitagliptin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,867,063 excl. VAT ### Lot LOT-0200: 200 | Solifenacin Filmtabletten \[3\] ATC-Code: G04BD08; Solifenacin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €440,164 excl. VAT ### Lot LOT-0201: 201 | Spironolacton Tabletten u.w. \[2\] ATC-Code: C03DA01; Spironolacton Darreichungsform(en): überzogene Tabletten; Filmtabletten; Kapseln; Tabletten; Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,390,691 excl. VAT ### Lot LOT-0202: 202 | Sultiam Filmtabletten \[1\] ATC-Code: N03AX03; Sultiam Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €211,582 excl. VAT ### Lot LOT-0203: 203 | Sumatriptan Filmtabletten u.w. \[3\] ATC-Code: N02CC01; Sumatriptan Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €683,621 excl. VAT ### Lot LOT-0204: 204 | Tacrolimus Salbe \[1\] ATC-Code: D11AH01; Tacrolimus Darreichungsform(en): Salbe Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €602,452 excl. VAT ### Lot LOT-0205: 205 | Tadalafil Filmtabletten BPH \[3\] \[H\] ATC-Code: G04BE08; Tadalafil Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €190,879 excl. VAT ### Lot LOT-0206: 206 | Tadalafil Filmtabletten PAH \[3\] \[H\] ATC-Code: G04BE08; Tadalafil Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €958,035 excl. VAT ### Lot LOT-0207: 207 | Tamsulosin Hartkapseln mit veränderter Wirkstofffreisetzung u.w. \[2\] ATC-Code: G04CA02; Tamsulosin Darreichungsform(en): Hartkapseln mit veränderter Wirkstofffreisetzung; Hartkapseln, retardiert; Retardtabletten; Retardkapseln; Retard-überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,630,126 excl. VAT ### Lot LOT-0208: 208 | Tapentadol Filmtabletten \[1\] ATC-Code: N02AX06; Tapentadol Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €740,191 excl. VAT ### Lot LOT-0209: 209 | Telmisartan + Amlodipin Tabletten \[1\] ATC-Code: C09DB04; Telmisartan + Amlodipin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €113,901 excl. VAT ### Lot LOT-0210: 210 | Telmisartan + Hydrochlorothiazid Tabletten u.w. \[3\] ATC-Code: C09DA07; Telmisartan + Hydrochlorothiazid Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €275,970 excl. VAT ### Lot LOT-0211: 211 | Telmisartan Tabletten u.w. \[3\] ATC-Code: C09CA07; Telmisartan Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €542,090 excl. VAT ### Lot LOT-0212: 212 | Temozolomid Hartkapseln \[3\] ATC-Code: L01AX03; Temozolomid Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,555,527 excl. VAT ### Lot LOT-0213: 213 | Tenofovir + Emtricitabin Filmtabletten \[2\] ATC-Code: J05AR03; Tenofovirdisoproxil + Emtricitabin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €615,386 excl. VAT ### Lot LOT-0214: 214 | Tenofovir Filmtabletten \[2\] ATC-Code: J05AF07; Tenofovirdisoproxil Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €568,583 excl. VAT ### Lot LOT-0215: 215 | Teriflunomid Filmtabletten \[3\] ATC-Code: L04AK02; Teriflunomid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €477,632 excl. VAT ### Lot LOT-0216: 216 | Testosteron Gel \[1\] ATC-Code: G03BA03; Testosteron Darreichungsform(en): Gel Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €180,092 excl. VAT ### Lot LOT-0217: 217 | Testosteron Injektionslösung \[2\] ATC-Code: G03BA03; Testosteron Darreichungsform(en): Injektionslösung Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,509,826 excl. VAT ### Lot LOT-0218: 218 | Tetrabenazin Tabletten \[2\] ATC-Code: N07XX06; Tetrabenazin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €146,321 excl. VAT ### Lot LOT-0219: 219 | Thiamazol Tabletten u.w. \[1\] ATC-Code: H03BB02; Thiamazol Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €99,755 excl. VAT ### Lot LOT-0220: 220 | Timolol + Brinzolamid Augentropfen \[1\] ATC-Code: S01ED51; Timolol + Brinzolamid Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €296,946 excl. VAT ### Lot LOT-0221: 221 | Timolol + Dorzolamid Augentropfen \[2\] ATC-Code: S01ED51; Timolol + Dorzolamid Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,055,436 excl. VAT ### Lot LOT-0222: 222 | Timolol + Latanoprost Augentropfen \[2\] ATC-Code: S01ED51; Timolol + Latanoprost Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €707,327 excl. VAT ### Lot LOT-0223: 223 | Timolol + Travoprost Augentropfen \[2\] ATC-Code: S01ED51; Timolol + Travoprost Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €151,468 excl. VAT ### Lot LOT-0224: 224 | Timolol Augentropfen \[1\] ATC-Code: S01ED01; Timolol Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €183,567 excl. VAT ### Lot LOT-0225: 225 | Tizanidin Tabletten \[1\] ATC-Code: M03BX02; Tizanidin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €124,471 excl. VAT ### Lot LOT-0226: 226 | Tolperison Filmtabletten \[2\] ATC-Code: M03BX04; Tolperison Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €205,975 excl. VAT ### Lot LOT-0227: 227 | Tolvaptan Tabletten ADPKD \[1\] \[H\] ATC-Code: C03XA01; Tolvaptan Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,552,713 excl. VAT ### Lot LOT-0228: 228 | Tolvaptan Tabletten SIADH \[2\] \[H\] ATC-Code: C03XA01; Tolvaptan Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €2,113,932 excl. VAT ### Lot LOT-0229: 229 | Torasemid Tabletten \[2\] ATC-Code: C03CA04; Torasemid Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €3,629,564 excl. VAT ### Lot LOT-0230: 230 | Tramadol Hartkapseln u.w. \[1\] ATC-Code: N02AX02; Tramadol Darreichungsform(en): Hartkapseln; Tabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €55,302 excl. VAT ### Lot LOT-0231: 231 | Tramadol Lösung zum Einnehmen u.w. \[3\] ATC-Code: N02AX02; Tramadol Darreichungsform(en): Lösung zum Einnehmen; Tropfen zum Einnehmen; Lösung; Pumplösung Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €170,478 excl. VAT ### Lot LOT-0232: 232 | Tramadol Retardtabletten u.w. (2x täglich) \[2\] \[H\] ATC-Code: N02AX02; Tramadol Darreichungsform(en): Hartkapseln, retardiert; Retardtabletten; Retardkapseln; (Applikationshäufigkeit 2 x täglich) Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €901,208 excl. VAT ### Lot LOT-0233: 233 | Tranexamsäure Filmtabletten \[1\] ATC-Code: B02AA02; Tranexamsäure Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €67,850 excl. VAT ### Lot LOT-0234: 234 | Travoprost Augentropfen \[2\] ATC-Code: S01EE04; Travoprost Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €96,291 excl. VAT ### Lot LOT-0235: 235 | Trazodon Tabletten \[2\] ATC-Code: N06AX05; Trazodon Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €492,818 excl. VAT ### Lot LOT-0236: 236 | Treprostinil Infusionslösung \[1\] ATC-Code: B01AC21; Treprostinil Darreichungsform(en): Infusionslösung Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €2,653,133 excl. VAT ### Lot LOT-0237: 237 | Triamteren + Hydrochlorothiazid Filmtabletten u.w. \[1\] ATC-Code: C03EA01; Triamteren + Hydrochlorothiazid Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €38,162 excl. VAT ### Lot LOT-0238: 238 | Urapidil Retardkapseln \[2\] ATC-Code: C02CA06; Urapidil Darreichungsform(en): Retardkapseln Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,709,665 excl. VAT ### Lot LOT-0239: 239 | Valaciclovir Filmtabletten \[1\] ATC-Code: J05AB11; Valaciclovir Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €65,567 excl. VAT ### Lot LOT-0240: 240 | Valganciclovir Filmtabletten \[2\] ATC-Code: J05AB14; Valganciclovir Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €463,249 excl. VAT ### Lot LOT-0241: 241 | Valproinsäure Lösung zum Einnehmen \[1\] ATC-Code: N03AG01; Valproinsäure Darreichungsform(en): Lösung zum Einnehmen Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €232,954 excl. VAT ### Lot LOT-0242: 242 | Valsartan + Amlodipin Filmtabletten \[3\] ATC-Code: C09DB01; Valsartan + Amlodipin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,693,403 excl. VAT ### Lot LOT-0243: 243 | Valsartan + Hydrochlorothiazid Filmtabletten \[3\] ATC-Code: C09DA03; Valsartan + Hydrochlorothiazid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €815,592 excl. VAT ### Lot LOT-0244: 244 | Valsartan Filmtabletten \[3\] ATC-Code: C09CA03; Valsartan Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,677,567 excl. VAT ### Lot LOT-0245: 245 | Valsartan, Amlodipin + Hydrochlorothiazid Filmtabletten \[2\] ATC-Code: C09DX01; Valsartan, Amlodipin + Hydrochlorothiazid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €1,648,563 excl. VAT ### Lot LOT-0246: 246 | Venlafaxin Retardkapseln u.w. \[3\] ATC-Code: N06AX16; Venlafaxin Darreichungsform(en): Hartkapseln, retardiert; Retardtabletten; Hartkapseln mit veränderter Wirkstofffreisetzung; Retardkapseln Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €2,033,334 excl. VAT ### Lot LOT-0247: 247 | Venlafaxin Tabletten \[2\] ATC-Code: N06AX16; Venlafaxin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €130,251 excl. VAT ### Lot LOT-0248: 248 | Verapamil Filmtabletten \[2\] ATC-Code: C08DA01; Verapamil Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €120,872 excl. VAT ### Lot LOT-0249: 249 | Verapamil Retardtabletten \[2\] ATC-Code: C08DA01; Verapamil Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €227,918 excl. VAT ### Lot LOT-0250: 250 | Vinorelbin Weichkapseln \[1\] ATC-Code: L01CA04; Vinorelbin Darreichungsform(en): Weichkapseln Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €191,721 excl. VAT ### Lot LOT-0251: 251 | Zidovudin + Lamivudin Filmtabletten \[1\] ATC-Code: J05AR01; Zidovudin + Lamivudin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €61,023 excl. VAT ### Lot LOT-0252: 252 | Zoledronsäure Infusionslösung 5mg \[1\] ATC-Code: M05BA08; Zoledronsäure Darreichungsform(en): Infusionslösung Anzahl der vorgesehenen Vertragspartner: 1 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €192,504 excl. VAT ### Lot LOT-0253: 253 | Zoledronsäure Infusionslösungskonzentrat \[2\] ATC-Code: M05BA08; Zoledronsäure Darreichungsform(en): Infusionslösungskonzentrat Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €195,844 excl. VAT ### Lot LOT-0254: 254 | Zolmitriptan Schmelztabletten u.w. \[2\] ATC-Code: N02CC03; Zolmitriptan Darreichungsform(en): Filmtabletten; Schmelztabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €121,433 excl. VAT ### Lot LOT-0255: 255 | Zolpidem Filmtabletten \[2\] ATC-Code: N05CF02; Zolpidem Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €150,324 excl. VAT ### Lot LOT-0256: 256 | Zonisamid Hartkapseln \[2\] ATC-Code: N03AX15; Zonisamid Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €435,063 excl. VAT ### Lot LOT-0257: 257 | Zopiclon Filmtabletten \[3\] ATC-Code: N05CF01; Zopiclon Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3 - CPV: Pharmaceutical products (CPV 33600000) - Published value: €422,086 excl. VAT ## Timeline - 27 July 2026, 15:42 (UTC+02:00): Award notice, Notice, version 01 (Contract or concession award notice – standard regime), [Official notice](https://oeffentlichevergabe.de/ui/de/notices/bec5121e-468c-4c24-85ed-9b280cfd52b5) - 29 July 2026, 16:25 (UTC+02:00): Award notice, Notice, version 01 (Contract or concession award notice – standard regime), [Official notice](https://oeffentlichevergabe.de/ui/de/notices/f51d4024-f7de-438f-b5f4-73e94e513e03) - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €662,842 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €662,842 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Dexcel Pharma GmbH; Award value: €662,842 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €662,842 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €662,842 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Dexcel Pharma GmbH; Award value: €662,842 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €489,005 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €489,005 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €489,005 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €489,005 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €489,005 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €489,005 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €847,633 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Bluefish Pharma GmbH; Award value: €847,633 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €847,633 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Bluefish Pharma GmbH; Award value: €847,633 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €950,165 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €950,165 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: HEC Pharm GmbH; Award value: €950,165 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €950,165 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €950,165 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: HEC Pharm GmbH; Award value: €950,165 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Hormosan Pharma GmbH; Award value: €427,767 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Hormosan Pharma GmbH; Award value: €427,767 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Holsten Pharma GmbH; Award value: €272,927 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €272,927 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Holsten Pharma GmbH; Award value: €272,927 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €272,927 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Holsten Pharma GmbH; Award value: €443,988 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €443,988 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €443,988 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Holsten Pharma GmbH; Award value: €443,988 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €443,988 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €443,988 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €689,008 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Neuraxpharm / Hexal GbR (H e x a l Aktiengesellschaft, neuraxpharm Arzneimittel GmbH); Award value: €689,008 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €689,008 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Neuraxpharm / Hexal GbR (H e x a l Aktiengesellschaft, neuraxpharm Arzneimittel GmbH); Award value: €689,008 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,652,640 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,652,640 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,652,640 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,652,640 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,652,640 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,652,640 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €455,487 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: HIKMA PHARMA GMBH; Award value: €455,487 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €455,487 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: HIKMA PHARMA GMBH; Award value: €455,487 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €866,300 excl. VAT; Tenders received: 13 - 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €866,300 excl. VAT; Tenders received: 13 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €866,300 excl. VAT; Tenders received: 13 - 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €866,300 excl. VAT; Tenders received: 13 - 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €866,300 excl. VAT; Tenders received: 13 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €866,300 excl. VAT; Tenders received: 13 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €138,588 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €138,588 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €138,588 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €138,588 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €68,962 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €68,962 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €68,962 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €68,962 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €421,487 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €421,487 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €421,487 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €421,487 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €421,487 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €421,487 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,722,952 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,722,952 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,722,952 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,722,952 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €98,025 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €98,025 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €617,329 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €617,329 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €617,329 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €617,329 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €240,653 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €240,653 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Klinge Pharma GmbH; Award value: €156,449 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Klinge Pharma GmbH; Award value: €156,449 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €384,408 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €384,408 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €384,408 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €384,408 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €413,198 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €413,198 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €413,198 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €413,198 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €288,667 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €288,667 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €321,627 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €321,627 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €321,627 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €321,627 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,507,223 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €2,507,223 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,507,223 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: 028 | Bisoprolol Filmtabletten u.w. \[3\]; Award value: €2,507,223 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €2,507,223 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,507,223 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,697,386 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €1,697,386 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,697,386 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €1,697,386 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €607,346 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €607,346 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €607,346 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €607,346 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €298,162 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €298,162 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €495,424 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €495,424 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: ETHYPHARM GmbH; Award value: €34,183 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: ETHYPHARM GmbH; Award value: €34,183 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Accord Healthcare B.V. vertreten durch Accord Healthcare GmbH; Award value: €2,520,709 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Basics GmbH; Award value: €2,520,709 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,520,709 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Accord Healthcare B.V. vertreten durch Accord Healthcare GmbH; Award value: €2,520,709 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Basics GmbH; Award value: €2,520,709 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,520,709 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €147,740 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €147,740 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Aristo Pharma GmbH; Award value: €2,038,709 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,038,709 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Aristo Pharma GmbH; Award value: €2,038,709 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,038,709 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,484,538 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,484,538 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,484,538 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,484,538 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,484,538 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,484,538 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €10,344,179 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €10,344,179 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €10,344,179 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €10,344,179 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €10,344,179 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €10,344,179 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Recordati Rare Diseases Germany GmbH; Award value: €1,415,752 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Recordati Rare Diseases Germany GmbH; Award value: €1,415,752 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €657,846 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €657,846 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €657,846 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €657,846 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €657,846 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €657,846 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €804,717 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €804,717 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €61,190 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Hormosan Pharma Gesellschaft mit beschränkter Haftung; Award value: €61,190 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €61,190 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Hormosan Pharma Gesellschaft mit beschränkter Haftung; Award value: €61,190 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €781,122 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €781,122 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €781,122 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €781,122 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €781,122 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €781,122 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €1,208,950 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €1,208,950 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €1,208,950 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €1,208,950 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €898,442 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €898,442 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €898,442 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €898,442 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €94,877 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €94,877 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €278,904 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €278,904 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €206,196 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €206,196 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €24,569 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €24,569 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €921,005 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €921,005 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €921,005 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €921,005 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €366,029 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €366,029 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €366,029 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €366,029 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,311,167 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €1,311,167 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,311,167 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,311,167 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €1,311,167 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,311,167 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €591,888 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €591,888 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Devatis GmbH; Award value: €36,558 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Devatis GmbH; Award value: €36,558 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,064,137 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,064,137 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €68,370 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €68,370 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €68,370 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €68,370 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Bayer Vital GmbH; Award value: €212,378 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €212,378 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Bayer Vital GmbH; Award value: €212,378 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €212,378 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €572,176 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €572,176 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €572,176 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €572,176 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: AAA-Pharma GmbH; Award value: €204,369 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €204,369 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: AAA-Pharma GmbH; Award value: €204,369 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €204,369 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €595,598 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €595,598 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €595,598 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €595,598 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €302,485 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €302,485 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €302,485 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €302,485 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €89,581 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €89,581 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Abdi Farma GmbH; Award value: €899,552 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €899,552 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €899,552 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: Abdi Farma GmbH; Award value: €899,552 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €899,552 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €899,552 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €512,606 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €512,606 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €512,606 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €512,606 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €190,024 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €190,024 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €190,024 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €190,024 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €497,502 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €497,502 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €497,502 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €497,502 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: ROVI GmbH; Award value: €5,397,408 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Venipharm S.A.S. vertreten durch Venipharm GmbH; Award value: €5,397,408 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: ROVI GmbH; Award value: €5,397,408 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Venipharm S.A.S. vertreten durch Venipharm GmbH; Award value: €5,397,408 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: HEC Pharm GmbH; Award value: €39,122 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: HEC Pharm GmbH; Award value: €39,122 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €298,737 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €298,737 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €298,737 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €298,737 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €37,223 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €37,223 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €254,039 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Ascend GmbH; Award value: €254,039 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €254,039 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €254,039 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Ascend GmbH; Award value: €254,039 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €254,039 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €102,983 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €102,983 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €102,983 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €102,983 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €1,962,275 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €1,962,275 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,962,275 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €1,962,275 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €1,962,275 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,962,275 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €270,507 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BIOCON PHARMA MALTA I LIMITED; Award value: €270,507 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €270,507 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BIOCON PHARMA MALTA I LIMITED; Award value: €270,507 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €258,507 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €258,507 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Devatis GmbH; Award value: €258,507 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €258,507 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €258,507 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Devatis GmbH; Award value: €258,507 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €332,751 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €332,751 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €332,751 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €332,751 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €332,751 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €332,751 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €254,081 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €254,081 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €254,081 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €254,081 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Phoenix Labs Unlimited Company; Award value: €48,375 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Phoenix Labs Unlimited Company; Award value: €48,375 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €822,136 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €822,136 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €822,136 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €822,136 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €40,508 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €40,508 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €757,139 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €757,139 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €385,841 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €385,841 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €385,841 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €385,841 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €639,231 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: Ascend GmbH; Award value: €639,231 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €639,231 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €639,231 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: Ascend GmbH; Award value: €639,231 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €639,231 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: Accord Healthcare B.V. vertreten durch Accord Healthcare GmbH; Award value: €744,475 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €744,475 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Accord Healthcare B.V. vertreten durch Accord Healthcare GmbH; Award value: €744,475 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €744,475 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €486,208 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €486,208 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €486,208 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €486,208 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €486,208 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €486,208 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €10,205,410 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €10,205,410 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Hormosan Pharma Gesellschaft mit beschränkter Haftung; Award value: €10,205,410 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €10,205,410 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €10,205,410 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Hormosan Pharma Gesellschaft mit beschränkter Haftung; Award value: €10,205,410 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €317,262 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €317,262 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €493,124 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: EVER Pharma GmbH; Award value: €493,124 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: HIKMA PHARMA GMBH; Award value: €493,124 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €493,124 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: EVER Pharma GmbH; Award value: €493,124 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: HIKMA PHARMA GMBH; Award value: €493,124 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €234,536 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €234,536 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €234,536 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €234,536 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €52,700 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €52,700 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €259,427 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €259,427 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €259,427 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €259,427 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Takeda GmbH; Award value: €1,292,206 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Takeda GmbH; Award value: €1,292,206 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: mibe GmbH Arzneimittel; Award value: €557,745 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €557,745 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: mibe GmbH Arzneimittel; Award value: €557,745 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €557,745 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €1,306,758 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,306,758 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €1,306,758 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,306,758 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Devatis GmbH; Award value: €340,103 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Medac Gesellschaft für klinische Spezialpräparate m.b.H.; Award value: €340,103 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Devatis GmbH; Award value: €340,103 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Medac Gesellschaft für klinische Spezialpräparate m.b.H.; Award value: €340,103 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Bluefish Pharma GmbH; Award value: €26,220 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Bluefish Pharma GmbH; Award value: €26,220 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Bluefish Pharma GmbH; Award value: €129,389 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Bluefish Pharma GmbH; Award value: €129,389 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €105,572 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €105,572 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €322,663 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €322,663 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €322,663 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €322,663 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,283,399 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €3,283,399 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,283,399 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €3,283,399 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Basics GmbH; Award value: €365,756 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Basics GmbH; Award value: €365,756 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €84,168 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €84,168 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €153,411 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €153,411 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €153,411 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €153,411 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €153,411 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €153,411 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €39,175 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €39,175 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €75,247 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €75,247 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €75,247 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €75,247 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Takeda GmbH; Award value: €551,748 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Takeda GmbH; Award value: €551,748 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €1,212,252 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: OmniVision; Award value: €1,212,252 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €1,212,252 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: OmniVision; Award value: €1,212,252 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Laboratoires THEA S.A.S. vertreten durch Théa Pharma GmbH; Award value: €1,272,238 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Laboratoires THEA S.A.S. vertreten durch Théa Pharma GmbH; Award value: €1,272,238 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,431,277 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €1,431,277 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,431,277 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €1,431,277 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Devatis GmbH; Award value: €398,282 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €398,282 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €398,282 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: Devatis GmbH; Award value: €398,282 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €398,282 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €398,282 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €654,598 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €654,598 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: Sun Pharmaceuticals Germany GmbH; Award value: €654,598 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €654,598 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €654,598 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: Sun Pharmaceuticals Germany GmbH; Award value: €654,598 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €2,352,368 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €2,352,368 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: Hormosan Pharma GmbH; Award value: €2,352,368 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €2,352,368 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €2,352,368 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: Hormosan Pharma GmbH; Award value: €2,352,368 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €34,605 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €34,605 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Devatis GmbH; Award value: €797,847 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Devatis GmbH; Award value: €797,847 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €281,402 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €281,402 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €281,402 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €281,402 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Exeltis Germany GmbH; Award value: €323,662 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Hormosan Pharma Gesellschaft mit beschränkter Haftung; Award value: €323,662 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Exeltis Germany GmbH; Award value: €323,662 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Hormosan Pharma Gesellschaft mit beschränkter Haftung; Award value: €323,662 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Bayer Vital GmbH; Award value: €141,550 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Exeltis Germany GmbH; Award value: €141,550 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Bayer Vital GmbH; Award value: €141,550 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Exeltis Germany GmbH; Award value: €141,550 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €3,777,219 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €3,777,219 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €3,777,219 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €3,777,219 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €189,292 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €189,292 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €189,292 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €189,292 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €233,342 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €233,342 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €233,342 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €233,342 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Pfizer Pharma GmbH; Award value: €285,774 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €285,774 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Pfizer Pharma GmbH; Award value: €285,774 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €285,774 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Ferring Arzneimittel GmbH; Award value: €759,356 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Tillotts Pharma GmbH; Award value: €759,356 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Ferring Arzneimittel GmbH; Award value: €759,356 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Tillotts Pharma GmbH; Award value: €759,356 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Dr. Falk Pharma GmbH; Award value: €781,708 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Dr. Falk Pharma GmbH; Award value: €781,708 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €4,776,515 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €4,776,515 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €4,776,515 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €4,776,515 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,412,194 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,412,194 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,412,194 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,412,194 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €3,356,442 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,356,442 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €3,356,442 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €3,356,442 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,356,442 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €3,356,442 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €2,001,479 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €2,001,479 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €2,001,479 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €2,001,479 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €146,102 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €146,102 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,008,468 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €1,008,468 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,008,468 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €1,008,468 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,618,070 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €3,618,070 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,618,070 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €3,618,070 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €176,572 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €176,572 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €176,572 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €176,572 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €197,032 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €197,032 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €72,539 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €72,539 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €75,406 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €75,406 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: nio Health GmbH; Award value: €665,363 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Pfizer Pharma GmbH; Award value: €665,363 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: nio Health GmbH; Award value: €665,363 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Pfizer Pharma GmbH; Award value: €665,363 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €2,300,359 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,300,359 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,300,359 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €2,300,359 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,300,359 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,300,359 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €632,835 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €632,835 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €632,835 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €632,835 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: ETHYPHARM GmbH; Award value: €268,296 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: ETHYPHARM GmbH; Award value: €268,296 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,651,900 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,651,900 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,651,900 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,651,900 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Nordmark Pharma GmbH; Award value: €4,128,382 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €4,128,382 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Nordmark Pharma GmbH; Award value: €4,128,382 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €4,128,382 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Grünenthal GmbH; Award value: €249,070 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Grünenthal GmbH; Award value: €249,070 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €151,549 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €151,549 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €151,549 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €151,549 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH) BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €4,150,194 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €4,150,194 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH) BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €4,150,194 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €4,150,194 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,867,997 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,867,997 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €1,867,997 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,867,997 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,867,997 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €1,867,997 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €720,240 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €720,240 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €720,240 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €720,240 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €720,240 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €720,240 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,845,574 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,845,574 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,845,574 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,845,574 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,845,574 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,845,574 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €2,210,072 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,210,072 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: G.L. Pharma GmbH vertreten durch G.L. Pharma Deutschland GmbH; Award value: €2,210,072 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €2,210,072 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,210,072 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: G.L. Pharma GmbH vertreten durch G.L. Pharma Deutschland GmbH; Award value: €2,210,072 excl. VAT; Tenders received: 11 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €3,225,518 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €3,225,518 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €3,225,518 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €3,225,518 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €6,996,120 excl. VAT; Tenders received: 12 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €6,996,120 excl. VAT; Tenders received: 12 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €6,996,120 excl. VAT; Tenders received: 12 - 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €6,996,120 excl. VAT; Tenders received: 12 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €6,996,120 excl. VAT; Tenders received: 12 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €6,996,120 excl. VAT; Tenders received: 12 - 8 July 2026: Award. Winner: Sun Pharmaceuticals Germany GmbH; Award value: €492,749 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Sun Pharmaceuticals Germany GmbH; Award value: €492,749 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €124,833 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €124,833 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €678,198 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €678,198 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €678,198 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €678,198 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €734,047 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €734,047 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €338,879 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €338,879 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €821,472 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €821,472 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,511,318 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,511,318 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,511,318 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,511,318 excl. VAT; Tenders received: 9 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,039,128 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €1,039,128 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €1,039,128 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,039,128 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €1,039,128 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €1,039,128 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €810,767 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €810,767 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €810,767 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €810,767 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €178,302 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €178,302 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €178,302 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €178,302 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,097,973 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Galenpharma GmbH; Award value: €1,097,973 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: mibe GmbH Arzneimittel; Award value: €1,097,973 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,097,973 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Galenpharma GmbH; Award value: €1,097,973 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: mibe GmbH Arzneimittel; Award value: €1,097,973 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Ascend GmbH; Award value: €5,119,295 excl. VAT; Tenders received: 15 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €5,119,295 excl. VAT; Tenders received: 15 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €5,119,295 excl. VAT; Tenders received: 15 - 8 July 2026: Award. Winner: Ascend GmbH; Award value: €5,119,295 excl. VAT; Tenders received: 15 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €5,119,295 excl. VAT; Tenders received: 15 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €5,119,295 excl. VAT; Tenders received: 15 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €58,138 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €58,138 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €143,243 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €143,243 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €483,328 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €483,328 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €483,328 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €483,328 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €430,301 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €430,301 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €110,282 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €110,282 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,028,562 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Devatis GmbH; Award value: €2,028,562 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €2,028,562 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,028,562 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Devatis GmbH; Award value: €2,028,562 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €2,028,562 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €599,172 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €599,172 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,364,230 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,364,230 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,364,230 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,364,230 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €3,036,130 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,036,130 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €3,036,130 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €3,036,130 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,036,130 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €3,036,130 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €200,985 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €200,985 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €200,985 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €200,985 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €200,985 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €200,985 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €62,403 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €62,403 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €62,403 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €62,403 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €595,421 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Dexcel Pharma GmbH; Award value: €595,421 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €595,421 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €595,421 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Dexcel Pharma GmbH; Award value: €595,421 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €595,421 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €34,505 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €34,505 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €435,668 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €435,668 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €435,668 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €435,668 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €880,509 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €880,509 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Luye Pharma AG; Award value: €880,509 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €880,509 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €880,509 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Luye Pharma AG; Award value: €880,509 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €296,232 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €296,232 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €296,232 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €296,232 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €137,311 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €137,311 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €137,311 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €137,311 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €320,471 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €320,471 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €320,471 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €320,471 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Adamed Pharma S.A. vertreten durch BERLIN-CHEMIE Aktiengesellschaft; Award value: €2,991,042 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,991,042 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Adamed Pharma S.A. vertreten durch BERLIN-CHEMIE Aktiengesellschaft; Award value: €2,991,042 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,991,042 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €3,070,443 excl. VAT; Tenders received: 12 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,070,443 excl. VAT; Tenders received: 12 - 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €3,070,443 excl. VAT; Tenders received: 12 - 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €3,070,443 excl. VAT; Tenders received: 12 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,070,443 excl. VAT; Tenders received: 12 - 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €3,070,443 excl. VAT; Tenders received: 12 - 8 July 2026: Award. Winner: Bluefish Pharma GmbH; Award value: €165,748 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Bluefish Pharma GmbH; Award value: €165,748 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,286,901 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,286,901 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €2,286,901 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,286,901 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,286,901 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €2,286,901 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €82,968 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €82,968 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,826,458 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €1,826,458 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,826,458 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €1,826,458 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €2,970,173 excl. VAT; Tenders received: 14 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €2,970,173 excl. VAT; Tenders received: 14 - 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €2,970,173 excl. VAT; Tenders received: 14 - 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €2,970,173 excl. VAT; Tenders received: 14 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €2,970,173 excl. VAT; Tenders received: 14 - 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €2,970,173 excl. VAT; Tenders received: 14 - 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €1,867,063 excl. VAT; Tenders received: 17 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €1,867,063 excl. VAT; Tenders received: 17 - 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €1,867,063 excl. VAT; Tenders received: 17 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €1,867,063 excl. VAT; Tenders received: 17 - 8 July 2026: Award. Winner: Ascend GmbH; Award value: €440,164 excl. VAT; Tenders received: 12 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €440,164 excl. VAT; Tenders received: 12 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €440,164 excl. VAT; Tenders received: 12 - 8 July 2026: Award. Winner: Ascend GmbH; Award value: €440,164 excl. VAT; Tenders received: 12 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €440,164 excl. VAT; Tenders received: 12 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €440,164 excl. VAT; Tenders received: 12 - 8 July 2026: Award. Winner: Accord Healthcare B.V. vertreten durch Accord Healthcare GmbH; Award value: €1,390,691 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,390,691 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Accord Healthcare B.V. vertreten durch Accord Healthcare GmbH; Award value: €1,390,691 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,390,691 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €211,582 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €211,582 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €683,621 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €683,621 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €683,621 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €683,621 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €683,621 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €683,621 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Dermapharm AG; Award value: €602,452 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Dermapharm AG; Award value: €602,452 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Abdi Farma GmbH; Award value: €190,879 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €190,879 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €190,879 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Abdi Farma GmbH; Award value: €190,879 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €190,879 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €190,879 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Abdi Farma GmbH; Award value: €958,035 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €958,035 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €958,035 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Abdi Farma GmbH; Award value: €958,035 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €958,035 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €958,035 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,630,126 excl. VAT; Tenders received: 10 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,630,126 excl. VAT; Tenders received: 10 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,630,126 excl. VAT; Tenders received: 10 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,630,126 excl. VAT; Tenders received: 10 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €740,191 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €740,191 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €113,901 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €113,901 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €275,970 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €275,970 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €275,970 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €275,970 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €275,970 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €275,970 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €542,090 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €542,090 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €542,090 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €542,090 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €542,090 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €542,090 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Accord Healthcare S.L.U. vertreten durch Accord Healthcare GmbH; Award value: €1,555,527 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Devatis GmbH; Award value: €1,555,527 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Medac Gesellschaft für klinische Spezialpräparate m.b.H.; Award value: €1,555,527 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Accord Healthcare S.L.U. vertreten durch Accord Healthcare GmbH; Award value: €1,555,527 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Devatis GmbH; Award value: €1,555,527 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Medac Gesellschaft für klinische Spezialpräparate m.b.H.; Award value: €1,555,527 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €615,386 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €615,386 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €615,386 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €615,386 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €568,583 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €568,583 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €568,583 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €568,583 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €477,632 excl. VAT; Tenders received: 13 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €477,632 excl. VAT; Tenders received: 13 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €477,632 excl. VAT; Tenders received: 13 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €477,632 excl. VAT; Tenders received: 13 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €477,632 excl. VAT; Tenders received: 13 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €477,632 excl. VAT; Tenders received: 13 - 8 July 2026: Award. Winner: Besins Healthcare Germany GmbH; Award value: €180,092 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Besins Healthcare Germany GmbH; Award value: €180,092 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Galenpharma GmbH; Award value: €1,509,826 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: mibe GmbH Arzneimittel; Award value: €1,509,826 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Galenpharma GmbH; Award value: €1,509,826 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: mibe GmbH Arzneimittel; Award value: €1,509,826 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: Aristo Pharma GmbH; Award value: €146,321 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €146,321 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Aristo Pharma GmbH; Award value: €146,321 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €146,321 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Aristo Pharma GmbH; Award value: €99,755 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Aristo Pharma GmbH; Award value: €99,755 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €296,946 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €296,946 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,055,436 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,055,436 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,055,436 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,055,436 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €707,327 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €707,327 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €707,327 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €707,327 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €151,468 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €151,468 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €183,567 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €183,567 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €124,471 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €124,471 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €205,975 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €205,975 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €205,975 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €205,975 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,552,713 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,552,713 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Accord Healthcare S.L.U. vertreten durch Accord Healthcare GmbH; Award value: €2,113,932 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Ascend GmbH; Award value: €2,113,932 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Accord Healthcare S.L.U. vertreten durch Accord Healthcare GmbH; Award value: €2,113,932 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Ascend GmbH; Award value: €2,113,932 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €3,629,564 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,629,564 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €3,629,564 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,629,564 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Libra-Pharm GmbH; Award value: €55,302 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Libra-Pharm GmbH; Award value: €55,302 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €170,478 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €170,478 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Libra-Pharm GmbH; Award value: €170,478 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €170,478 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €170,478 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Libra-Pharm GmbH; Award value: €170,478 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €901,208 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Libra-Pharm GmbH; Award value: €901,208 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €901,208 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Libra-Pharm GmbH; Award value: €901,208 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €67,850 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €67,850 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €96,291 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €96,291 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €492,818 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €492,818 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €492,818 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €492,818 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,709,665 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,709,665 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €65,567 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €65,567 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €463,249 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €463,249 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €463,249 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €463,249 excl. VAT; Tenders received: 7 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €232,954 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €232,954 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,693,403 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,693,403 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €1,693,403 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,693,403 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,693,403 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €1,693,403 excl. VAT; Tenders received: 8 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft)BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €815,592 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €815,592 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €815,592 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft)BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €815,592 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €815,592 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €815,592 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,677,567 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,677,567 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €1,677,567 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,677,567 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,677,567 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €1,677,567 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,648,563 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €1,648,563 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,648,563 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €1,648,563 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: AAA-Pharma GmbH; Award value: €2,033,334 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €2,033,334 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,033,334 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: AAA-Pharma GmbH; Award value: €2,033,334 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €2,033,334 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,033,334 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €130,251 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Dexcel Pharma GmbH; Award value: €130,251 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €130,251 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: Dexcel Pharma GmbH; Award value: €130,251 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €120,872 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €120,872 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €120,872 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €120,872 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €227,918 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €227,918 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €191,721 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €191,721 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €61,023 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €61,023 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €192,504 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €192,504 excl. VAT; Tenders received: 1 - 8 July 2026: Award. Winner: Denk Pharma GmbH & Co. KG; Award value: €195,844 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €195,844 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Denk Pharma GmbH & Co. KG; Award value: €195,844 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €195,844 excl. VAT; Tenders received: 2 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €121,433 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €121,433 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €121,433 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €121,433 excl. VAT; Tenders received: 3 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €150,324 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €150,324 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €150,324 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €150,324 excl. VAT; Tenders received: 4 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €435,063 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €435,063 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €435,063 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €435,063 excl. VAT; Tenders received: 6 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €422,086 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €422,086 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €422,086 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €422,086 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €422,086 excl. VAT; Tenders received: 5 - 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €422,086 excl. VAT; Tenders received: 5 ## Classification - CPV codes: Pharmaceutical products (CPV 33600000) - Other parties in the notice: 028 | Bisoprolol Filmtabletten u.w. \[3\] (Tenderer); 089Pharm GmbH (Tenderer); AAA-Pharma GmbH (Tenderer); Abdi Farma GmbH (Tenderer); Accord Healthcare B.V. vertreten durch Accord Healthcare GmbH (Tenderer); Accord Healthcare S.L.U. vertreten durch Accord Healthcare GmbH (Tenderer); Adamed Pharma S.A. vertreten durch BERLIN-CHEMIE Aktiengesellschaft (Tenderer); Amarox Pharma GmbH (Tenderer); Aristo Pharma GmbH (Tenderer); Ascend GmbH (Tenderer); BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH) (Tenderer); BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH) (Tenderer); BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH) BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH) (Tenderer); BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft) (Tenderer); BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft)BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft) (Tenderer); BG Neuraxpharm / Hexal GbR (H e x a l Aktiengesellschaft, neuraxpharm Arzneimittel GmbH) (Tenderer); BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH) (Tenderer); BIOCON PHARMA MALTA I LIMITED (Tenderer); Basics GmbH (Tenderer); Bayer Vital GmbH (Tenderer); Besins Healthcare Germany GmbH (Tenderer); Bluefish Pharma GmbH (Tenderer); Denk Pharma GmbH & Co. KG (Tenderer); Dermapharm AG (Tenderer); Devatis GmbH (Tenderer); Dexcel Pharma GmbH (Tenderer); Dr. Falk Pharma GmbH (Tenderer); ETHYPHARM GmbH (Tenderer); EVER Pharma GmbH (Tenderer); Exeltis Germany GmbH (Tenderer); Ferring Arzneimittel GmbH (Tenderer); G.L. Pharma GmbH vertreten durch G.L. Pharma Deutschland GmbH (Tenderer); Galenpharma GmbH (Tenderer); Glenmark Arzneimittel GmbH (Tenderer); Grünenthal GmbH (Tenderer); HEC Pharm GmbH (Tenderer); HEC Pharm GmbH (Tenderer); HIKMA PHARMA GMBH (Tenderer); Holsten Pharma GmbH (Tenderer); Hormosan Pharma Gesellschaft mit beschränkter Haftung (Tenderer); Hormosan Pharma GmbH (Tenderer); Klinge Pharma GmbH (Tenderer); Laboratoires THEA S.A.S. vertreten durch Théa Pharma GmbH (Tenderer); Libra-Pharm GmbH (Tenderer); Luye Pharma AG (Tenderer); Macleods Pharma Espana S.L.U. (Tenderer); Medac Gesellschaft für klinische Spezialpräparate m.b.H. (Tenderer); Medical Valley Invest AB (Tenderer); Micro Labs GmbH (Tenderer); Nordmark Pharma GmbH (Tenderer); OmniVision (Tenderer); PUREN Pharma GmbH & Co. KG (Tenderer); Pfizer Pharma GmbH (Tenderer); Phoenix Labs Unlimited Company (Tenderer); ROVI GmbH (Tenderer); Recordati Rare Diseases Germany GmbH (Tenderer); Sun Pharmaceuticals Germany GmbH (Tenderer); TAD Pharma GmbH (Tenderer); Takeda GmbH (Tenderer); Tillotts Pharma GmbH (Tenderer); Venipharm S.A.S. vertreten durch Venipharm GmbH (Tenderer); Viatris Healthcare GmbH (Tenderer); Vivanta Generics s.r.o. (Tenderer); Zentiva Pharma GmbH (Tenderer); axunio Pharma GmbH (Tenderer); betapharm Arzneimittel GmbH (Tenderer); mibe GmbH Arzneimittel (Tenderer); neuraxpharm Arzneimittel GmbH (Tenderer); nio Health GmbH (Tenderer); 028 | Bisoprolol Filmtabletten u.w. \[3\] (Winner); 089Pharm GmbH (Winner); AAA-Pharma GmbH (Winner); Abdi Farma GmbH (Winner); Accord Healthcare B.V. vertreten durch Accord Healthcare GmbH (Winner); Accord Healthcare S.L.U. vertreten durch Accord Healthcare GmbH (Winner); Adamed Pharma S.A. vertreten durch BERLIN-CHEMIE Aktiengesellschaft (Winner); Amarox Pharma GmbH (Winner); Aristo Pharma GmbH (Winner); Ascend GmbH (Winner); BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH) (Winner); BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH) (Winner); BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH) BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH) (Winner); BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft) (Winner); BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft)BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft) (Winner); BG Neuraxpharm / Hexal GbR (H e x a l Aktiengesellschaft, neuraxpharm Arzneimittel GmbH) (Winner); BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH) (Winner); BIOCON PHARMA MALTA I LIMITED (Winner); Basics GmbH (Winner); Bayer Vital GmbH (Winner); Besins Healthcare Germany GmbH (Winner); Bluefish Pharma GmbH (Winner); Denk Pharma GmbH & Co. KG (Winner); Dermapharm AG (Winner); Devatis GmbH (Winner); Dexcel Pharma GmbH (Winner); Dr. Falk Pharma GmbH (Winner); ETHYPHARM GmbH (Winner); EVER Pharma GmbH (Winner); Exeltis Germany GmbH (Winner); Ferring Arzneimittel GmbH (Winner); G.L. Pharma GmbH vertreten durch G.L. Pharma Deutschland GmbH (Winner); Galenpharma GmbH (Winner); Glenmark Arzneimittel GmbH (Winner); Grünenthal GmbH (Winner); HEC Pharm GmbH (Winner); HEC Pharm GmbH (Winner); HIKMA PHARMA GMBH (Winner); Holsten Pharma GmbH (Winner); Hormosan Pharma Gesellschaft mit beschränkter Haftung (Winner); Hormosan Pharma GmbH (Winner); Klinge Pharma GmbH (Winner); Laboratoires THEA S.A.S. vertreten durch Théa Pharma GmbH (Winner); Libra-Pharm GmbH (Winner); Luye Pharma AG (Winner); Macleods Pharma Espana S.L.U. (Winner); Medac Gesellschaft für klinische Spezialpräparate m.b.H. (Winner); Medical Valley Invest AB (Winner); Micro Labs GmbH (Winner); Nordmark Pharma GmbH (Winner); OmniVision (Winner); PUREN Pharma GmbH & Co. KG (Winner); Pfizer Pharma GmbH (Winner); Phoenix Labs Unlimited Company (Winner); ROVI GmbH (Winner); Recordati Rare Diseases Germany GmbH (Winner); Sun Pharmaceuticals Germany GmbH (Winner); TAD Pharma GmbH (Winner); Takeda GmbH (Winner); Tillotts Pharma GmbH (Winner); Venipharm S.A.S. vertreten durch Venipharm GmbH (Winner); Viatris Healthcare GmbH (Winner); Vivanta Generics s.r.o. (Winner); Zentiva Pharma GmbH (Winner); axunio Pharma GmbH (Winner); betapharm Arzneimittel GmbH (Winner); mibe GmbH Arzneimittel (Winner); neuraxpharm Arzneimittel GmbH (Winner); nio Health GmbH (Winner) ## Official documents No documents found in the indexed notice. ## Questions and answers ### Who is the buyer? IKK classic, Dresden, DE. ### What is being procured (CPV)? Pharmaceutical products (CPV 33600000). ### Is it divided into lots? Yes, into 257 lots: 001 | Acetylsalicylsäure magensaftresistente Tabletten u.w. \[3\] \[H\], 002 | Agomelatin Filmtabletten \[3\], 003 | Alendronsäure Tabletten u.w. \[2\], 004 | Allopurinol Tabletten \[3\], 005 | Amifampridin Tabletten \[1\], 006 | Amisulprid Filmtabletten \[2\], 007 | Amisulprid Tabletten \[3\], 008 | Amitriptylin Filmtabletten u.w. \[2\] and 249 more. ### Which procedure is used? Open. ### How do I submit a bid? On the official notice or the portal it names. Inteliwert does not submit bids. [Official notice](https://oeffentlichevergabe.de/ui/de/notices/f51d4024-f7de-438f-b5f4-73e94e513e03) ### Am I eligible? Inteliwert does not judge eligibility. The selection criteria are in the official notice. [Official notice](https://oeffentlichevergabe.de/ui/de/notices/f51d4024-f7de-438f-b5f4-73e94e513e03) ## More from this buyer Other published opportunities of this buyer in the indexed notices, open ones first. - [Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren](https://inteliwert.com/tender/opp_6SCRQ3JNS8QAKYKEYWB8M14YCH/arzneimittelrabattvertraege-gem-130a-abs-8-sgb-v-im-rahmen-von-open-house-verfah) Open · Buyer: IKK classic · Place: DED21 (Sachsen) · Deadline: 5 Sept 2028, 23:59 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/7ad430a7-26c5-4230-9ff4-1e948502c5e4), Last checked 7 Nov 2026, 14:30 (UTC+01:00) - [Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren](https://inteliwert.com/tender/opp_SH0FBJ2SDH14XGX076PHVW3DG7/arzneimittelrabattvertraege-gem-130a-abs-8-sgb-v-im-rahmen-von-open-house-verfah) Open · Buyer: IKK classic · Place: DED21 (Sachsen) · Deadline: 5 Jul 2028, 23:59 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/90e38bd0-40a2-47b5-b826-d7e01809c1d6), Last checked 10 Nov 2026, 01:31 (UTC+01:00) - [Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der Besins Healthcare Germany GmbH zu Testogel](https://inteliwert.com/tender/opp_DBVJ21DCT83S74MBFJADD63HTM/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch) Awarded · Buyer: IKK classic · Published value: €1 excl. VAT · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/c2226235-cbac-4d13-93aa-f1e37775f2e7), Last checked 6 Nov 2026, 07:11 (UTC+01:00) - [Abschluss eines nicht-exklusiven Rabattvertrages gemäߧ 130c Abs. 1 SGB V zwischen der IKK classic und Abacus Medicine und Originalis B.V. zu Bimzelx](https://inteliwert.com/tender/opp_SDAPHC4SAB22RJ065HJBQXRSFY/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130c-abs-1-sgb-v-zwisch) Awarded · Buyer: IKK classic · Place: DED21 (Sachsen) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/3f2ce9a6-42ef-4f31-a8fc-d56f0174b61d), Last checked 4 Nov 2026, 12:10 (UTC+01:00) - [Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der G.L. Pharma Deutschland GmbH zu Remosan](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch) Awarded · Buyer: IKK classic · Published value: €1 excl. VAT · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/67d115f8-8c7e-4c29-b909-1a4d3a78c7a2), Last checked 7 Nov 2026, 13:30 (UTC+01:00) ## Related opportunities - [Lieferung von 68 m³ MGO-Gasöl (unversteuert) für den Maschinenbetrieb des VWFS DENEB & des VS CAPELLA am 28.07.2026 im Stadthafen von Rostock](https://inteliwert.com/tender/opp_4FX1VEYMJ8QZXRGGX1E29BVRPK/lieferung-von-68-m-mgo-gasoel-unversteuert-fuer-den-maschinenbetrieb-des-vwfs-de) Open · Place: DE8 (Mecklenburg-Vorpommern) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/513880aca0e2f501), Last checked 10 Nov 2026, 01:31 (UTC+01:00) - [Arzneimittel mit dem Wirkstoff Nebivolol (ATC: C07AB12)](https://inteliwert.com/tender/opp_4VP64RP4YFW98HHTKB7X7FV1YD/arzneimittel-mit-dem-wirkstoff-nebivolol-atc-c07ab12) Open · Buyer: AOK Sachsen - Anhalt · Place: DEE03 (Sachsen-Anhalt) · Deadline: 31 Jul 2028, 00:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/80060e25-8ba4-4303-9c91-d26e55dacbd4), Last checked 10 Nov 2026, 01:31 (UTC+01:00) - [Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V ab dem 01.09.2026](https://inteliwert.com/tender/opp_6SA269X2NSGP5428J75D8SG2XC/abschluss-nicht-exklusiver-rabattvereinbarungen-nach-130-a-abs-8-sgb-v-ab-dem-01) Open · Buyer: GWQ ServicePlus AG · Place: DEA11 (Nordrhein-Westfalen) · Deadline: 10 May 2028, 10:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/c58c00d1-5914-4276-862c-b47e91e65773), Last checked 10 Nov 2026, 01:31 (UTC+01:00) - [Arzneimittel mit dem Wirkstoff Aprepitant (ATC: A04AD12 - in der Darreichungsform Hartkapseln)](https://inteliwert.com/tender/opp_98EQRTD2JB8AY1FPDSSMZDMSX5/arzneimittel-mit-dem-wirkstoff-aprepitant-atc-a04ad12-in-der-darreichungsform-ha) Open · Buyer: AOK Sachsen - Anhalt · Place: DEE03 (Sachsen-Anhalt) · Deadline: 31 Jul 2028, 00:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/9b87c3fb-cc12-4cf3-97b5-de5c6fa5498f), Last checked 10 Nov 2026, 01:31 (UTC+01:00) - [Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens](https://inteliwert.com/tender/opp_AF7JN3331VNYKY5GCGQVCD2NA0/abschluss-nicht-exklusiver-rabattvereinbarungen-nach-130a-abs-8-sgb-v-zu-verschi) Open · Buyer: AOK Nordost. Die Gesundheitskasse. · Place: DE404 (Brandenburg) · Deadline: 5 Aug 2028, 23:58 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/e21c1b61-f3de-4b74-a663-134f01228749), Last checked 10 Nov 2026, 01:31 (UTC+01:00) - [Arzneimittel mit dem Wirkstoff Interferon beta-1a (ATC: L03AB07 - zur subkutanen Anwendung)](https://inteliwert.com/tender/opp_D4TSKJWPABT004ZJMXV9J5AKP9/arzneimittel-mit-dem-wirkstoff-interferon-beta-1a-atc-l03ab07-zur-subkutanen-anw) Open · Buyer: AOK Sachsen - Anhalt · Place: DEE03 (Sachsen-Anhalt) · Deadline: 31 Jul 2028, 00:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/b9fc3f3d-7230-421d-86d0-2a0b55f18f99), Last checked 10 Nov 2026, 01:31 (UTC+01:00) ## Source - Publisher: Bekanntmachungsservice - Licence: [CC0 1.0](https://creativecommons.org/publicdomain/zero/1.0/) - Official notice: [https://oeffentlichevergabe.de/ui/de/notices/f51d4024-f7de-438f-b5f4-73e94e513e03](https://oeffentlichevergabe.de/ui/de/notices/f51d4024-f7de-438f-b5f4-73e94e513e03) - Last checked: 9 November 2026, 20:30 (UTC+01:00) The official notice is authoritative. Inteliwert shows what the notice states and links to it. --- Page: https://inteliwert.com/tender/opp_1CR5ZMNMQ3G57237KNGFVPKRVZ/arzneimittelausschreibung-2026-vergebene-auftraege Inteliwert is a product of Bandpey GmbH, an international data and AI software company in Munich, Germany, founded and led by Roozbeh Bandpey. Bandpey's products: Facthory, Emolysis, Copolly and Inteliwert. Inteliwert on LinkedIn: https://www.linkedin.com/company/intelliwert, GitHub: https://github.com/inteliwertai.